- Home
- EPOW vs NRXS Comparison
EPOW vs NRXS Comparison
Compare EPOW & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPOW
- NRXS
- Stock Information
- Founded
- EPOW 2014
- NRXS 2011
- Country
- EPOW China
- NRXS United States
- Employees
- EPOW N/A
- NRXS N/A
- Industry
- EPOW Business Services
- NRXS
- Sector
- EPOW Consumer Discretionary
- NRXS
- Exchange
- EPOW Nasdaq
- NRXS Nasdaq
- Market Cap
- EPOW 24.1M
- NRXS 25.0M
- IPO Year
- EPOW 2021
- NRXS 2023
- Fundamental
- Price
- EPOW $0.88
- NRXS $2.42
- Analyst Decision
- EPOW
- NRXS Strong Buy
- Analyst Count
- EPOW 0
- NRXS 1
- Target Price
- EPOW N/A
- NRXS $7.00
- AVG Volume (30 Days)
- EPOW 14.6K
- NRXS 52.6K
- Earning Date
- EPOW 05-15-2025
- NRXS 08-12-2025
- Dividend Yield
- EPOW N/A
- NRXS N/A
- EPS Growth
- EPOW N/A
- NRXS N/A
- EPS
- EPOW N/A
- NRXS N/A
- Revenue
- EPOW $64,997,741.00
- NRXS $3,217,531.00
- Revenue This Year
- EPOW N/A
- NRXS $62.14
- Revenue Next Year
- EPOW N/A
- NRXS $131.87
- P/E Ratio
- EPOW N/A
- NRXS N/A
- Revenue Growth
- EPOW 44.28
- NRXS 41.93
- 52 Week Low
- EPOW $0.70
- NRXS $1.33
- 52 Week High
- EPOW $1.36
- NRXS $6.20
- Technical
- Relative Strength Index (RSI)
- EPOW 44.96
- NRXS 45.99
- Support Level
- EPOW $0.86
- NRXS $2.42
- Resistance Level
- EPOW $1.00
- NRXS $2.68
- Average True Range (ATR)
- EPOW 0.03
- NRXS 0.12
- MACD
- EPOW -0.00
- NRXS 0.00
- Stochastic Oscillator
- EPOW 17.93
- NRXS 39.25
About EPOW Sunrise New Energy Co. Ltd
Sunrise New Energy Co Ltd is engaged in the manufacturing and sale of graphite anode material for EVs and other lithium-ion batteries. The Company's joint venture is in the construction of a manufacturing plant in Guizhou Province. The plant runs on inexpensive electricity from renewable sources that enables the group to be a low-cost and low environmental impact producer of graphite anode material, Its products include GS-1, GS-2, GS-3, GZD-1, GLD-1, and GZ-1.
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).